Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
European Commission approves Sanofi’s Teizeild to treat patients with stage 2 type 1 diabetes: Paris Tuesday, January 13, 2026, 11:00 Hrs [IST] The European Commission has appro ...
Pixel users can now open apps faster with the keyboard's enter key, instead of tapping the app icon.
Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...
Anthropic is pushing into the healthcare market as it launches artificial intelligence tools and resources purpose-built for ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...
In a powerful push for AI in healthcare, Anthropic has launched a dedicated set of tools under Claude for medical queries and ...
PCMag Australia on MSN
I Investigated Every Windows 12 Clue. These Are the Features I'm Betting Will Actually Arrive
Microsoft hasn't confirmed Windows 12 yet, but leaked code, insider previews, and the latest Copilot+ PC updates hint at ...
OmniOutliner 6 offers multiple powerful improvements and new features that will make any outlining task even more streamlined ...
While a lot of people (yes, even adults) think of vegetables as a bummer, there is a whole lot of science behind their health ...
Anthropic launches Claude for Healthcare, expanding AI tools for clinicians, insurers, and patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results